Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)

This study is currently recruiting participants.

Study NCT00422591 Information provided by M.D. Anderson Cancer Center

First Received: January 16, 2007 Last Updated: September 15, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	October 2010
Estimated Primary Completion Date:	October 2010 (Final data collection date for primary outcome measure)